Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford BioMedica

Showing 15 posts of 18 posts found.

Oxford Biomedica acquires ABL Europe for €15m

January 30, 2024
Business Services ABL Europe, Oxford BioMedica, Pharmacy, acquisition

Oxford Biomedica has announced that it has completed the acquisition of ABL Europe from Institut Mérieux. This follows announcements on …

News
shutterstock_2

Oxford Biomedica joins forces with UK’s Vaccines Manufacturing and Innovation Centre to scale up production of Oxford Uni’s COVID-19 vaccine

June 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Oxford BioMedica, University of Oxford, Vaccine, coronavirus, pharma

Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …

News
novo_flag

Novo Holdings invests £53.5 million into Oxford Biomedica

May 30, 2019
Business Services, Sales and Marketing Novo Holdings, Novo Nordisk, Oxford BioMedica, Shares, cell and gene therapy, lentivirus

Novo Holdings has agreed to buy 10.1% of shares in British firm Oxford Biomedica for £53.5 million. Novo will buy …

News
ob_logo

Oxford Biomedica to expand with fourth site, creating 100 jobs

September 13, 2018
Oxford BioMedica, pharma

Gene and cell therapy group Oxford Biomedica has announced plans to expand its business with a new site located not …

News
handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018
Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …

News
ob_logo

Oxford BioMedica in $100 million manufacturing deal with Novartis

July 6, 2017
Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica

Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …

News

Novartis signs $90m deal with Oxford BioMedica

October 10, 2014
Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb

UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …

News
ABPI image

ABPI and BIA establish new manufacturing partnership

September 23, 2014
Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip

The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …

News
screen_shot_2014-08-18_at_07

Oxford BioMedica takes on executive position

August 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioMedica, blake

Gene and cell therapy firm Oxford BioMedica has confirmed that non-executive director Dr Paul Blake has been appointed to the …

Appointment
pfizer_reflection

Oxford BioMedica gains $1 million Pfizer pay-out

August 29, 2013
Research and Development, Sales and Marketing Cancer, Oxford BioMedica, Pfizer, TroVax

News
tim_watts

Oxford BioMedica makes management change

February 10, 2012
Research and Development, Sales and Marketing Oxford BioMedica

Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …

Appointment
oxford_biomedica__manufacturing_james_christie

James Christie joins Oxford BioMedica as manufacturing head

February 22, 2011
Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production

UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …

Appointment

Oxford BioMedica buys decommissioned facility

February 1, 2011
Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

News

Oxford BioMedica hopes vaccine first will raise interest

May 5, 2010
Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax

Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …

News

Oxford BioMedica encouraged by phase I/II Parkinson’s trial

July 15, 2009
Research and Development Oxford BioMedica, Prosavin

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026